Form 4: Eric Topol, Dexcom Inc. Director, Acquires 2,618 Shares of Common Stock

Director Eric Topol acquired 2,618 shares of Dexcom Inc. common stock on May 22, 2024, through a restricted stock unit (RSU) award.

Summary

• On May 22, 2024, Eric Topol, a director of Dexcom Inc., acquired 2,618 shares of common stock.
• The acquisition was made through a restricted stock unit (RSU) award.
• The RSU award was granted on May 22, 2024, and will vest 100% on the earlier of the one-year anniversary of the grant date or the date of DexCom, Inc.'s 2025 Annual Meeting of Stockholders.
• The price of the acquired shares was $0.0.
• Following the transaction, Eric Topol directly owns 2,618 shares of Dexcom Inc. common stock and indirectly owns 377,927 shares through family holdings.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a stock transaction. The acquisition of shares by a director is mildly positive, suggesting confidence, but it's not a major event.

Positives

• A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The RSU award will vest on the earlier of the one-year anniversary of the grant date or the date of DexCom, Inc.'s 2025 Annual Meeting of Stockholders.

Industry Context

This is a routine disclosure of a director's stock transaction, which is common in publicly traded companies. It provides transparency to investors regarding the holdings of company insiders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding insider ownership.

Key Dates